GAM
IRWD icon

Gotham Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Gotham Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.4K Buy
+10,657
New +$43.7K ﹤0.01% 1743
2024
Q4 		– Sell
-23,766
Closed -$97.9K – 1470
2024
Q3 		$97.9K Sell
23,766
-36,394
-60% -$196K ﹤0.01% 1375
2024
Q2 		$392K Sell
60,160
-13,794
-19% -$97.6K 0.01% 1154
2024
Q1 		$644K Buy
73,954
+11,903
+19% +$144K 0.01% 968
2023
Q4 		$710K Buy
62,051
+40,672
+190% +$402K 0.01% 887
2023
Q3 		$206K Sell
21,379
-71,663
-77% -$702K ﹤0.01% 1238
2023
Q2 		$990K Sell
93,042
-18,817
-17% -$202K 0.02% 773
2023
Q1 		$1.18M Buy
111,859
+36,537
+49% +$409K 0.03% 702
2022
Q4 		$933K Sell
75,322
-37,240
-33% -$422K 0.03% 705
2022
Q3 		$1.17M Buy
112,562
+68,247
+154% +$774K 0.03% 600
2022
Q2 		$511K Sell
44,315
-46,671
-51% -$550K 0.02% 778
2022
Q1 		$1.15M Sell
90,986
-96,666
-52% -$1.11M 0.04% 522
2021
Q4 		$2.19M Buy
187,652
+77,582
+70% +$952K 0.07% 327
2021
Q3 		$1.44M Buy
110,070
+15,440
+16% +$200K 0.06% 386
2021
Q2 		$1.22M Buy
94,630
+76,193
+413% +$872K 0.05% 436
2021
Q1 		$206K Buy
18,437
+1,875
+11% +$19.8K 0.01% 945
2020
Q4 		$189K Sell
16,562
-38,198
-70% -$418K 0.01% 939
2020
Q3 		$493K Buy
54,760
+8,917
+19% +$88.6K 0.02% 737
2020
Q2 		$473K Sell
45,843
-35,345
-44% -$362K 0.01% 757
2020
Q1 		$819K Sell
81,188
-36,284
-31% -$426K 0.02% 602
2019
Q4 		$1.56M Buy
117,472
+86,110
+275% +$949K 0.03% 523
2019
Q3 		$269K Buy
31,362
+2,066
+7% +$20.1K ﹤0.01% 938
2019
Q2 		$320K Sell
29,296
-30,605
-51% -$343K 0.01% 939
2019
Q1 		$679K Buy
59,901
+44,294
+284% +$495K 0.01% 767
2018
Q4 		$135K Buy
+15,607
New +$179K ﹤0.01% 951
2017
Q4 		– Sell
-40,971
Closed -$541K – 992
2017
Q3 		$541K Sell
40,971
-170,312
-81% -$2.34M 0.01% 686
2017
Q2 		$3.34M Sell
211,283
-222,200
-51% -$3.23M 0.05% 438
2017
Q1 		$6.19M Buy
433,483
+276,874
+177% +$3.79M 0.08% 344
2016
Q4 		$2M Sell
156,609
-20,074
-11% -$254K 0.03% 511
2016
Q3 		$2.35M Buy
176,683
+16,901
+11% +$198K 0.03% 471
2016
Q2 		$1.75M Buy
+159,782
New +$1.56M 0.02% 541
2014
Q3 		– Sell
-33,180
Closed -$426K – 1028
2014
Q2 		$426K Buy
+33,180
New +$361K 0.01% 807

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Gotham Asset Management's IRWD Position: Q1 2026 in Review

Gotham Asset Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 10,657 shares worth $37.4K. The stake represents ﹤0.01% of the portfolio and ranks #1743 among its holdings. This is a return to the name: Gotham Asset Management previously reported a position in IRWD as recently as Q3 2024.

Gotham Asset Management first reported a position in IRWD in Q2 2014 and has held it in 32 quarters since. The position peaked at $6.19M in Q1 2017. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Gotham Asset Management held 10,657 shares of Ironwood Pharmaceuticals worth $37.4K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Gotham Asset Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Gotham Asset Management's portfolio in Q1 2026, its #1743 holding.
  • Gotham Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 32 quarters since.
  • Gotham Asset Management's Ironwood Pharmaceuticals position peaked at $6.19M in Q1 2017.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.